OraSure Technologies, Inc. is a leading provider of diagnostic tests, specimen collection devices and microbiome laboratory and analytical services. The company's operations span across the United States, Europe, and internationally, operating in two segments - Diagnostics and Molecular Solutions. OraSure's diagnostic products include the InteliSwab COVID-19 rapid test, Intercept drug testing systems and a range of HIV self-tests. The company also offers genomic products for collecting human saliva, microbiome laboratory testing and analytical services, as well as other in vitro diagnostic tests. OraSure markets its products to a diverse range of customers, including clinical laboratories, hospitals, clinics, distributors, government agencies, physicians' offices, and commercial and industrial entities. The company was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
OraSure's ticker is OSUR
The company's shares trade on the NASDAQ stock exchange
They are based in Bethlehem, Pennsylvania
There are 201-500 employees working at OraSure
It is orasure.com
OraSure is in the Healthcare sector
OraSure is in the Medical Instruments & Supplies industry
The following five companies are OraSure's industry peers: